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Abstract
Dendritic cells (DC) are potent antigen-presenting cells capable of inducing T and B responses and immune tolerance. We have characterized
some aspects of energy metabolism accompanying the differentiation process of human monocytes into DC. Compared to precursor monocytes,
DC exhibited a much larger number of mitochondria and consistently (i) a higher endogenous respiratory activity and (ii) a more than sixfold
increase in ATP content and an even larger increase in the activity of the mitochondrial marker enzyme citrate synthase. The presence in the
culture medium of rotenone, an inhibitor of the respiratory chain Complex I, prevented the increase in mitochondrial number and ATP level,
without affecting cell viability. Rotenone inhibited DC differentiation, as revealed by the observation that the expression of CD1a, which is a
specific surface marker of DC differentiation, was strongly reduced. Cells cultured in the presence of rotenone displayed a lower content of growth
factor-induced, mitochondrially generated, hydrogen peroxide. A similar drop in ROS was observed upon addition of catalase, which caused
functional effects similar to those produced by rotenone treatment. These results suggest that ROS play a crucial role in DC differentiation and that
mitochondria are an important source of ROS in this process.
© 2008 Elsevier Inc. All rights reserved.
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Effective immune responses require correct localization and
functioning of dendritic cells (DC). Dendritic cells are the most
potent and versatile antigen-presenting cells, with a unique
ability to induce specific immune responses as well as tolerance
[1,2]. In peripheral tissues they reside in an immature state
waiting for incoming antigens. After capturing and processing
the antigens, DC undergo a maturation process which culmi-
nates in dramatic changes in functions and migratory properties
[3,4]. The localization of mature DC to the draining lymph
nodes coincides with the presentation of processed antigens to
naïve T cells, triggering the initiation of specific immune re-
sponses [2,5]. An in vitro method to differentiate immature DC
from CD14+ monocyte precursors cultured in the presence of
granulocyte–macrophage colony-stimulating factor (GM-CSF)
and interleukin-4 (IL-4) is very well established [6,7].
Reactive oxygen species (ROS) have been identified as im-
portant secondmessengers involved in the transduction of several
signaling pathways [8,9], gene expression, and cell proliferation
[10]. Furthermore, recent studies have shown that growth factors,
through the actions of their specific receptors, are able to increase
Available online at www.sciencedirect.com
Free Radical Biology & Medicine 44 (2008) 1443–1451
www.elsevier.com/locate/freeradbiomed
Abbreviations: DC, dendritic cells; ROS, reactive oxygen species; GM-CSF,
granulocyte–macrophage colony-stimulating factor; IL-4, interleukin-4; CCCP,
carbonyl cyanide 3-chlorophenylhydrazone; DTNB, 5,5′-dithiobis-(2-nitroben-
zoic acid); DCFH-DA, 2′,7′-dichlorodihydrofluorescein diacetate; LDH, lactate
dehydrogenase.
⁎ Corresponding author. Department of Medical Biochemistry, Biology, and
Physics, University of Bari, 70124 Bari, Italy. Fax: +39 080 5478109.
E-mail address: m.lorusso@biochem.uniba.it (M. Lorusso).
1 These authors contributed equally to this work.
0891-5849/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.freeradbiomed.2007.12.037
Author's personal copy
the relative levels of intracellular ROS [11,12]. However, the
mechanism involved and the origin of intracellular ROS are not
well understood [13].
The main source of ROS during normal metabolism is re-
presented by the mitochondrial electron-transport chain activity
[14]. In particular, Complex I and Complex III have been iden-
tified as the major sites of ROS formation [15,16]. An alternative
site of ROS production is the NADPH oxidase multicomponent
enzyme system, which is very well characterized in phagocytic
cells (neutrophils and macrophages) as an essential mechanism
of defense against pathogens [17–19]. Recent studies showed
that, whereas NADPH oxidase activation is required for DC
killing of intracellular Escherichia coli, no role in DC differ-
entiation or functions can be ascribed to NADPH oxidase-
derived oxygen radicals [20,21]. However, an involvement of
ROS has been recently described in the activation and matu-
ration process of DC [22–24].
The present study was aimed at characterizing the differ-
entiation from monocyte precursors into immature DC, in terms
of biochemical features as well as phenotypical and functional
aspects. In particular, we addressed the question whether ROS
are involved in the differentiation process. Based on the effects
elicited by the respiratory chain Complex I inhibitor rotenone
on the morphological as well as biochemical alterations accom-
panying the differentiation, we suggest that the increased levels
of ROS, which seem to trigger the process, depend on the
mitochondrial respiratory activity.
Materials and methods
Cell culture media and reagents
rhGM-CSF and rhIL-4 were from R&D Systems (Minnea-
polis, MN, USA). Cytokines were endotoxin free as assessed by
the Limulus amebocyte assay (BioWhittaker, Walkersville, MD,
USA). FITC–dextran, catalase, rotenone, oligomycin, carbonyl
cyanide 3-chlorophenylhydrazone (CCCP), protease inhibitor
cocktail, 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), bovine
heart lactate dehydrogenase (LDH), NAD+, and the biolumines-
cence somatic cell ATP assay kit were purchased from Sigma (St.
Louis, MO, USA). The annexin V–FITC/propidium iodide apo-
ptosis detection kit was obtained fromBDBioscience (Mountain
View, CA, USA). 2′,7′-Dichlorodihydrofluorescein diacetate
(DCFH-DA) and MitoTracker red were from Invitrogen–
Molecular Probes (Eugene, OR, USA).
Dendritic cell culture generation and characterization
Peripheral blood mononuclear cells were isolated by standard
Ficoll–Paque (Amersham, Buckinghamshire, UK) gradient cen-
trifugation from buffy coats (obtained through the courtesy of the
local blood bank, Polyclinic Hospital, Bari, Italy). Monocytes
were purified by immunomagnetic separation using anti-CD14-
conjugated magnetic microbeads (Miltenyi, Bergisch Gladbach,
Germany) and cultured for 6 days at 1×106/ml in RPMI 1640
medium (Biochrom AG, Berlin, Germany) supplemented with
10% heat-inactivated FBS (Euro Clone, Milan, Italy), GM-CSF
(50 ng/ml), and IL-4 (20 ng/ml). DC maturation was induced by
the addition of lipopolysaccharide (LPS) at the final concentra-
tion of 100 ng/ml. Cells were cultured for a further 48 h.
In rotenone experiments, 50 nM rotenone was added to the
culture medium 10 min after GM-CSF and IL-4. After a further
10-min incubation, the cell suspension was supplemented with
10% FBS and cultured for 6 days. In catalase experiments
monocytes were incubated 15 min with 500 IU/ml catalase
before the addition of GM-CSF, IL-4, and FBS. Respiratory
activity in monocytes was inhibited by around 75% by rotenone,
whereas it was unaffected by catalase.
Surface phenotype analysis was performed using anti-CD14
(Miltenyi), anti-CD1a (Serotec, Oxford, UK), anti-CD83, and
anti-CCR5 monoclonal antibodies (R&D Systems). Mannose
receptor-mediated endocytosis was analyzed by FITC–dextran
uptake at 37°C. Cells were analyzed with a FACScan flow
cytometer (BD Bioscience) using CellQuest software.
Electron microscopy
Monocytes and DC were fixed for 2 h in 0.1 M phosphate
buffer containing 3% glutaraldehyde, washed in the same buf-
fer, and then postfixed in 1% OsO4 at 4°C. Afterward, cells
were scraped with a rubber bar, dehydrated in graded ethanol,
and embedded in Epon 812. Sixty-nanometer ultrathin sections
were cut with a diamond knife on a LKB-V Ultratome, stained
with uranyl acetate followed by lead citrate, and examined
under a Zeiss EM 109 electron microscope. For the morphome-
trical analysis, mitochondria of 50 cells for each sample were
counted on the electron micrographs at a final magnification of
12,000× by computer-aided analysis.
The mean value in each micrograph, the final mean value for
all themicrographs, and the standard error (SEM)were calculated.
Measurement of oxygen consumption rate
Cellular respiratory activity was measured polarographically
with a Clark-type electrode (Yellow Spring Instruments, Yellow
Spring, OH, USA), in an all-glass reaction chamber, magne-
tically stirred, at 37°C. Monocytes (4×106) or DC (2×106)
were suspended in 0.5 ml of PBS containing 5 mM glutamine,
5 mM pyruvate, and 2.5 mM malate. State 4 and uncoupled
respiration were obtained by adding 2 μg/ml oligomycin and
0.5 μM CCCP.
Determination of citrate synthase activity
Citrate synthase activity was measured spectrophotometri-
cally by following the reduction of DTNB at 412–360 nm
(ε=13.6 mM−1 ×cm−1). Cells (1×106) were pelleted and
resuspended in 0.2 ml of a medium containing 25 mM phosphate
buffer (pH 7.4), 5 mM MgCl2, and 1 μl of protease inhibitor
cocktail. After freezing and thawing three times, aliquots (20 to
120 μl) of the suspension were added to a reaction mixture
consisting of 10 mM Tris–Cl buffer (pH 7.4), 0.3 mM acetyl-
coenzyme A, 0.2 mM DTNB, and 0.2% (v/v) Triton X-100. The
reaction was started by the addition of 0.5 mM oxaloacetate.
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Measurement of intracellular ATP content
ATP concentration was determined using a bioluminescence
somatic cell assay kit, following the manufacturer's instructions.
We used 2×104 cells of each sample. Chemiluminescence signals
were acquired with a Perkin–Elmer Wallac 1420 VICTOR3 mul-
tilabel plate reader.
Measurement of lactate production
Analysis of lactate released into the culture medium was
carried out spectrophotometrically by following NAD+ reduc-
tion at 340 nm (ε=6.22 mM−1 × cm−1), essentially as described
in [25]. Briefly, 100 μl of cell suspension was withdrawn from
culture plates and centrifuged. Cell-free supernatants were added
to 900 μl of a medium containing 467 mM glycine, 280 mM
hydrazine sulfate, 2.6mMEDTA (pH 9.5), and 1mMNAD+ and
the reaction was started by adding 10 IU of LDH.
Fluorimetric determination of intracellular ROS
Intracellular ROS levels were determined by measuring fluo-
rescence intensity (excitation at 475 nm, emission at 525 nm) in
cells suspended in serum-free medium and loaded with the
redox-sensitive dyeDCFH-DA [26]. The nonfluorescent DCFH-
DA readily diffuses into the cells, where it is hydrolyzed to the
polar derivative DCFH, which is in turn oxidized in the presence
of H2O2 to the highly fluorescent DCF. Cells (1×10
6/ml) were
incubated with 5 μM DCFH-DA in the dark at 37°C. After
30 min incubation, cells were thoroughly washed quickly with a
pulse spin and immediately suspended in 1ml of PBS. The ROS-
dependent oxidation of DCFH-DA to the fluorescent derivative
was measured with a Jasco FP6200 spectrofluorimeter.
Laser scanning confocal microscopy
Monocytes (1×106/ml) were incubated with 200 nM Mito-
Tracker red and 5 μMDCFH-DA, for 30 min at 37°C in the dark.
At the end of incubation, cells were washed two times with cold
PBS and transferred onto a glass microscope slide. Confocal
microscopy was performed with a Nikon Eclipse E600 micro-
scope (Nikon Corp., Tokyo, Japan), equipped with argon-ion
and helium–neon lasers, emitting at 488- and 543-nm wave-
lengths. Fluorescent signals emitted by DCF and MitoTracker
red were quantified with the Nikon EZ C1 software (Nikon
Corp., version 2.10, Coord Automatisering), which allows the
quantitation of the fluorescence intensity profile of the pixels
within a defined area including a single cell. Fluorescence
intensities of the individual cells in both emission channels were
corrected for the background by repeating the procedure in a
cell-free field.
Statistical analysis
Results are expressed as means±SEM. Statistical signifi-
cance was determined using Student's t test. Differences were
considered significant when pb0.05.
Results
Characterization of themitochondrial oxidative phosphorylation
system in monocytes and DC
The results of experiments aimed at characterizing the mito-
chondrial oxidative phosphorylation system in monocytes and
DC are summarized in Fig. 1. The respirometric analysis shows
that the differentiation of monocytes into DC was accompanied
by a more than fivefold increase in endogenous respiratory
activity (Fig. 1A). This activity was substantially inhibited by
the ATP synthase inhibitor oligomycin and only slightly stimu-
lated by the subsequent addition of the protonophore uncoupler
CCCP, indicating that mitochondria were in an active (phosphory-
lating) state. The increase in respiratory control ratio (uncoupler-
stimulated vs oligomycin-inhibited respiration) observed in DC
with respect to monocytes indicates an improvement in mito-
chondrial coupling during the differentiation process. This finding
is substantiated by a significant increase in intracellular ATP
content (Fig. 1B, open circles), which is in turn paralleled by the
increase in the activity of the matrix marker enzyme citrate
synthase (Fig. 1B, closed circles). LPS-induced maturation of DC,
which was characterized by up regulation (around 90% positive
cells) of CD83 and down regulation of CCR5 expression, did not
Fig. 1. Mitochondrial enzymatic activities in monocytes and monocyte-derived
DC. (A) Cellular respiratory rate was measured in monocytes and in monocyte-
derived DC cultured for 6 days as described under Materials and methods. ER,
endogenous respiration. Where indicated oligomycin (Oligo, 2 μg/ml) and CCCP
(0.5 μM) were added. RCR, respiratory control ratio as uncoupled vs oligomycin-
inhibited respiratory rate (⁎⁎pb0.01 and ⁎⁎⁎pb0.001DCvsmonocytes). (B)Citrate
synthase activity (closed circles) and intracellular ATP content (open circles)
during the differentiation process frommonocytes into DC. Values are reported as
means±SEM from at least three different experiments.
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cause any significant variation in either the endogenous respi-
ratory activity or the respiratory control ratio. Citrate synthase
activity was also measured in mature DC and found to be almost
unchanged (not shown).
Ultrastructural features of monocytes and DC
Ultrastructurally, monocytes appeared as rounded cells with a
few organelles and a high nuclear-to-cytoplasmic ratio. They
showed small mitochondria characterized by a large intermem-
brane space, irregularly swollen cristae, and electron-dense
matrix (“condensed”mitochondria). Moreover, “orthodox”mito-
chondria, having a thin intermembrane space, slender and tubu-
lar cristae, and electron-transparent matrix, were also present
(Fig. 2A). DC appeared as flat cells with abundant cytoplasm
containing an irregularly sized nucleus, characterized by plasma
membranes with numerous fillipodes and pseudopodes. More-
over, DC displayed a significant increment in the number of
condensed mitochondria compared with monocytes (Fig. 2B).
The presence of rotenone in the culture medium gave rise to
cells exhibiting a significant reduction in the number of mito-
chondria compared with control DC. Furthermore, mitochondria
showed an electron-lucent matrix with evident lamellar cristae
and an easily recognizable orthodox conformation (Fig. 2C).
Lipid droplets and profiles of rough endoplasmic reticulum were
also present. The statistical analysis of these data is reported in
Fig. 2D. The cell viability tested by propidium iodide/annexin V
double staining was never below 90% either in control or in
rotenone-treated cells (not shown).
Phenotypical and functional characterization
For monitoring DC differentiation we examined the surface
density of CD14, a classical marker of monocytes, and of CD1a,
which is specific for DC. The time course of CD14 and CD1a
expression during the differentiation process is shown in Fig. 3.
In control DC CD14 expression significantly started to decline
at day +2, tending to disappear over the 6-day culture period,
whereas in rotenone-treated DC around 30% positive cells were
still detected at the end of the culture period (Fig. 3A). Con-
versely, rotenone-treated DC showed very low levels of CD1a
over the time investigated, whereas control DC reached a very
high level of expression of this marker at day +6 of the culture
(≈80%) (Fig. 3B). A statistical analysis of five independent
experiments is reported in Fig. 3C. Chemokine receptor charac-
terization of rotenone-treated cells showed that CCR5 expres-
sion was severely reduced (around 70%) compared to control
DC (not shown).
Fig. 2. Transmission electron microscopic examination. (A) Monocytes. The inset shows mitochondria exhibiting orthodox (arrow) and condensed (arrowhead)
conformation. (B) Dendritic cell lined at the plasma membrane with fillipodes and pseudopodes (arrowhead) and showing the cytoplasm with numerous condensed
mitochondria (inset). (C) Rotenone (Rot)-treated DC showing cytoplasm with lipid droplets (L) and mitochondria with orthodox conformation (inset). Scale bars
(original magnification): (A) 1.13 µm (inset, 0.25 µm); (B) 1.13 µm (inset, 0.41 µm); (C) 0.35 µm (inset, 0.24 µm). (D) Statistical analysis of the number of
mitochondria/μm2 in monocytes, DC, and rotenone-treated DC. Mean values±SEM are indicated (⁎pb0.05 DC vs monocytes; ⁎⁎pb0.01 DC Rot vs DC).
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The endocytic activity of DC, measured by monitoring the
uptake of FITC–dextran, is shown in Fig. 3D. After the differ-
entiation, immature DC showed a fivefold increased endocytic
activity compared to monocytes. However, in rotenone-treated
DC the FITC–dextran uptake was largely decreased. All the
above results indicate that the addition of rotenone impairs the
differentiation process of monocytes into DC.
Fig. 4 shows the effects of rotenone on cellular ATP content
and lactate production during DC differentiation. Rotenone
treatment, although ineffective at day +1, resulted subsequently
in a reduction in the ATP content increase induced by the
differentiation process (Fig. 4A). This effect was accompanied
by a progressively increased release of lactate into the culture
medium (Fig. 4B), indicating a change in the metabolic and
energetic state of these cells.
Analysis of GM-CSF-induced ROS production
GM-CSF has been reported to cause a rapid increase in ROS
production in several cell lines [11,27,28]. Thus, experiments were
carried out to ascertain whether GM-CSF increased ROS gene-
ration in monocytes. ROS production was measured in monocytes
cultured either in the absence or in the presence of rotenone
(Fig. 5). The maximal ROS production, revealed by DCF fluo-
rescence, was observed early within 10–30 min after the addition
of growth factors and consisted in around a twofold increase
compared to the basal level, then a leaning plateau was reached
(Fig. 5, left). The presence of rotenone in the monocyte culture
induced a significant decrease in ROS levels (43.2% inhibition)
(Fig. 5, right). Moreover, when a classical antioxidant such as
catalase was used instead of rotenone, a similar drop in ROS
production was observed. Catalase treatment also caused a signi-
ficant reduction in CD1a expression (42±8.2%, n=3, positive
cells at day +6), comparable to that observed in rotenone-treated
cells (see Fig. 3). Furthermore, the respiratory activity measured at
day +6 in catalase-treated cells was lower than that exhibited by
control DC (1.7±0.2 vs 3.4±0.5 nmol O2/min/10
6cells). Impor-
tantly, catalase did not affect the respiratory activity when added to
precursor monocytes. These results suggest that the differentiation
process of DC can be regulated through the action of intracellular
redox state induced by growth factors on monocytes.
Laser scanning confocal microscopy analysis showed that
DCF fluorescence colocalized with MitoTracker red, a mito-
chondrial-specific probe, consistent with a prevalent contribu-
tion of the organelle to ROS formation (Fig. 6A). Rotenone
treatment resulted in a decrease in DCF fluorescence, whereas it
was ineffective on MitoTracker red fluorescence. Fluorescence
intensity profile analysis (Fig. 6B) showed that rotenone de-
creased the green fluorescence by around 50% (cf. Fig. 5).
Discussion
We have characterized here mitochondrial functions of human
monocytes andmonocyte-derived DC. DC exhibit a much higher
endogenous respiratory activity compared to monocytes and a
substantially higher respiratory control ratio (Fig. 1). This find-
ing, together with the observation that DC seemed to respire
Fig. 3. Phenotypical and functional analysis of DC: effect of rotenone. (A) CD14
and (B) CD1a expression during the differentiation process. Values are
expressed as percentage of positive cells. (C) Statistical analysis from five
independent experiments. Mean values±SEM are indicated (⁎pb0.05 and
⁎⁎pb0.01 DC Rot vs DC Ctr). (D) FITC–dextran uptake, expressed as mean
fluorescence intensity (MFI), in monocytes, DC, and rotenone-treated DC.
Values are means±SEM from at least three experiments (⁎pb0.05 DC Rot vs
DC Ctr; ⁎⁎pb0.01 DC Ctr vs monocytes).
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prevalently under State 3, at least under test conditions, would
indicate a high capacity of these cells to synthesize ATP. This
suggestion is substantiated by direct measurements of ATP pro-
duction during the differentiation process. After a lag of 1 day,
ATP production increased following almost a saturation curve.
The activity of citrate synthase, which is amatrixmarker enzyme,
nearly paralleled the increase inATP production. It is conceivable
that the dynamic changes in energy metabolism would prepare
DC to support energy-dependent processes such as endocytic
activity, which greatly increases during the differentiation pro-
cess (Fig. 3D). Increased ATP production would also be required
to support DC migration. This role for mitochondrial ATP has
recently been found in Tcells, wheremitochondrial redistribution
occurs in the cytoplasm to regulate the motor of these migratory
cells [27]. Whether mitochondria redistribute during DC migra-
tion has to be still ascertained.
TEM analysis revealed that an active mitochondrial biogen-
esis took place during the differentiation andmay account for the
increased respiratory and citrate synthase activities, as well as
ATP production. These morphological and functional changes
are triggered by the addition of GM-CSF and interleukin-4 to the
culture medium of monocytes. GM-CSF is known to induce a
rapid increase in ROS for signaling [11,28,29]. Under our ex-
perimental conditions a peak of ROS generation was observed
within 10–30 min after the addition of GM-CSF to monocytes,
whereas ATP production and citrate synthase activity start to
increase at least 1 day after. Thus the increased ROS generation
seems to precede the readjustment of energy metabolism and to
be a cause rather than a consequence of the increased mito-
chondrial mass accompanying cell differentiation.
The origin of ROS associatedwith the action of growth factors
is widely investigated. We have used in this work rotenone, the
inhibitor of the respiratory chain Complex I, to modulate mito-
chondrial basal ROS generation. This approach, which has been
pursued in many laboratories, has produced conflicting results
reporting that rotenone could elevate cellular ROS generation
in some cases [16,30,31], but reduce ROS production in others
[12,15,32–34]. Data have recently been produced showing that
ROS generated during the oxidation of NAD-dependent
substrates are greatly enhanced by rotenone and exclusively
released into the mitochondrial matrix [15,16], where they are
dissipated by the matrix antioxidant defense. Mn-SOD will form
Fig. 5. GM-CSF-induced ROS generation in monocytes: effects of rotenone and catalase. Fluorimetric determination of ROS production was carried out as described
under Materials and methods. Left: Time course of ROS production in monocytes initiated by the addition of GM-CSF and IL-4. Right: Effects of rotenone and
catalase treatment on ROS production. Values reported (arbitrary units, means±SEM from four separate experiments) refer to ROS detected 10–30 min after GM-CSF
addition (⁎pb0.05 catalase-treated vs control monocytes; ⁎⁎pb0.01 rotenone-treated vs control monocytes).
Fig. 4. Effects of rotenone on intracellular ATP content and lactate production
during the differentiation process. (A) ATP levels, expressed as nmol ATP/106
cells, were measured from day 0, in monocytes, up to day +6, in DC differ-
entiated in the absence or presence of rotenone. The means±SEM of at least
three independent experiments are indicated (⁎pb0.05 and ⁎⁎⁎pb0.001 DC Rot
vs DC Ctr). (B) Lactate released in the culture medium was assayed as described
under Materials and methods. Values are expressed as μM lactate released and
are the means±SEM from three different experiments (⁎⁎⁎pb0.001 DC Rot vs
DC Ctr).
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H2O2 from superoxide, with H2O2 in turn inactivated by
glutathione peroxidase or catalase when present [35,36]. In
contrast, electron transport within Complex III causes an
antimycin-promoted production of ROS which are released on
both sides of the inner membrane [15,16]. The hydrogen peroxide
now generated at the cytosolic side of the inner membrane leaks
out from the mitochondria and can be detected by suitable
measuring systems. Thus, according to this model, rotenone,
while inducing a substantial increase inmatrix hydrogen peroxide
from Complex I-generated superoxide anion, would cause a
decrease in cytosolic hydrogen peroxide deriving from Complex
III, just by limiting electron flow into this complex. It is then
possible that rotenone treatment of cells or isolated mitochondria
oxidizing NAD-linked substrates can result in either a decrease or
an increase in extramitochondrial hydrogen peroxide generation,
depending on the cell type involved and, in particular, on the
activity of matrix antioxidant systems. This point needs, however,
further investigation to be better defined.
We have shown here that rotenone caused a significant decrease
in ROS production by mitochondria in GM-CSF-stimulated
monocytes (Figs. 5 and 6) and this was accompanied by impair-
ment of their differentiation as revealed by the inhibition of the
endocytic activity (Fig. 3D), reduction in the dynamic changes of
themitochondrial energymetabolism (Fig. 4), as well as low levels
of the marker CD1a (Figs. 3B and C). The latter effects were also
elicited by catalase treatment, which caused a comparable drop in
ROS generation (Fig. 5). These results indicate that ROS, as
demonstrated in the activation and maturation processes [22–24],
also play a crucial role in DC differentiation and that mitochondria
are an important source of ROS in the process.
The question may then arise whether rotenone inhibits DC
differentiation by an indirect mechanism, for example, by caus-
ing energy failure. Although such effect cannot be excluded
along the various differentiation steps, the above hypothesis is
unlike because (i) the presence of rotenone did not impair cell
viability and rotenone-treated cells exhibit mitochondria in the
Fig. 6. Confocal microscopy analysis of monocytes. (A) Control and rotenone-treated GM-CSF-stimulated monocytes were incubated for 30 min in the presence of the
indicated dyes and analyzed by confocal microscopy (for details see Materials and methods and the legend to Fig. 5). The images are representative of three different
experiments. (B) Quantitative analysis of green (DCF) and red (MitoTracker) fluorescence signals was carried out on 10 randomly selected single cells from different
microscopic fields for each experiment. The values of fluorescence intensity (arbitrary units) are means±SEM (⁎⁎⁎pb0.001 Rot vs Ctrl).
1449A. Del Prete et al. / Free Radical Biology & Medicine 44 (2008) 1443–1451
Author's personal copy
orthodox conformation, as revealed by TEM analysis (Fig. 2C);
(ii) 1 day after the addition of rotenone, ATP production, mostly
supported by anaerobic glycolysis (Fig. 4B), was almost similar
to that found in control DC and was continuously increasing
in the remaining days, although to a lesser extent with respect
to control DC (Fig. 4A); and (iii) the rotenone effect was
reproduced by catalase, which did not affect the oxidative
phosphorylation.
As it has been widely suggested, ROS may act as a second
messenger by a mechanism including modulation of the thiol
proteome. This in turn would control the activity of protein
kinases and phosphatases. Sattler et al. did in fact show that
rotenone-sensitive mitochondrial ROS as well as exogenously
given hydrogen peroxide induced an increase in tyrosine phos-
phorylation of cellular proteins and inhibition of protein phos-
phatases in hematopoietic cells [12]. Furthermore Watanabe
et al. showed that mitochondrially generated hydrogen peroxide
led to the activation of extracellular signal-regulated kinase in
endothelial cells [31].
It is worthwhile considering, however, that rotenone addition
to cell culture causes, on the other hand, a substantial increase in
cellular NADH, because under these conditions cells are depen-
dent on glycolysis for ATP generation (see Fig. 4). Thus the
possibility that the DC differentiation process may depend on the
reduction level of the NAD+/NADH couple also has to be con-
sidered. Such a role for NADH has been recently suggested by
Pelicano et al. [37], who found that in rotenone-treated parental
Raji cancer cells as well as in derived clones of respiration-
deficient cells (ρ−), the increase in NADH level inactivated the
phosphatase PTEN through a redox-mediated mechanism. Thus,
it can be hypothesized that the cellular redox tone may regulate
the sensitivity of redox signaling pathways to ROS in the DC
differentiation process.
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